{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:38:35Z","timestamp":1775065115696,"version":"3.50.1"},"reference-count":28,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,3,8]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare patients with SLE associated with either Evans syndrome (ES) or an isolated autoimmune cytopenia (immune thrombocytopenia (ITP) or autoimmune haemolytic anaemia (AIHA)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multicentre retrospective study including patients with SLE presenting with ITP, AIHA or ES of clinical significance (ie, requiring therapeutic intervention according to European Alliance of Associations for Rheumatology guidelines or clinician discretion). Clinical, laboratory and outcome data were compared between patients with ES and those with ITP or AIHA. Severe SLE flares were defined as flares with SLE Disease Activity Index \u226510.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 95 patients with SLE included, 30 had ES, 43 ITP and 22 AIHA. The number of severe SLE flares per patient was higher in ES than in ITP (1.3 vs 0.4, p=0.0004) and patients with AIHA (0.4, p=0.006). Patients with ES had a higher incidence rate ratio (IRR) of severe SLE flares (IRR\u202f=3.03; 95%\u2009CI 1.50 to 6.41), which remained significant in inverse probability of treatment weighting analyses. At last follow-up, patients with ES presented higher rates of renal (36.7% vs 9.3%, p=0.007) and neurological (36.7% vs 11.6%, p=0.019) involvement than patients with ITP. Severe infections were more frequent in patients with ES than ITP (47% vs 23%, p=0.045), with a higher mean number of severe infections per patient (1.2 vs 0.5, p=0.04).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with SLE, ES is associated with an increased risk of severe flares than isolated autoimmune cytopenia. These findings were consistent after adjustment for baseline imbalances, supporting ES as a high-risk SLE phenotype.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001866","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:36:17Z","timestamp":1775057777000},"page":"e001866","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Evans syndrome and isolated autoimmune cytopenias in SLE: a retrospective study"],"prefix":"10.1136","volume":"13","author":[{"given":"Thomas","family":"El-Jammal","sequence":"first","affiliation":[{"name":"H\u00f4pital de la Croix Rousse,Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"},{"name":"UMR CNRS 5305 Laboratoire de Biologie Tissulaire et Ing\u00e9nierie Th\u00e9rapeutique, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0954-0220","authenticated-orcid":false,"given":"Anne","family":"Fabre-Barthez","sequence":"additional","affiliation":[{"name":"H\u00f4pital de la Croix Rousse,Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Martinet","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Lyon Sud, Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micka\u00ebl","family":"Roussotte","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Lyon Sud, Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Hot","sequence":"additional","affiliation":[{"name":"H\u00f4pital Edouard Herriot, Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Baudet","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Annecy Genevois Hospital, \u00c9pagny Metz-Tessy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Lyon Sud, Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Lyon Sud, Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"P\u00e9rard","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre Hospitalier Saint Joseph Saint Luc, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1281-0433","authenticated-orcid":false,"given":"Thomas","family":"Barba","sequence":"additional","affiliation":[{"name":"H\u00f4pital Edouard Herriot, Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"S\u00e8ve","sequence":"additional","affiliation":[{"name":"H\u00f4pital de la Croix Rousse,Service de M\u00e9decine Interne, Hospices Civils de Lyon, Lyon, France"},{"name":"Research On Healthcare Performance, INSERM U1290, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2026040108352068000_13.1.e001866.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.07.001"},{"key":"2026040108352068000_13.1.e001866.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00413-1"},{"key":"2026040108352068000_13.1.e001866.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.24020"},{"key":"2026040108352068000_13.1.e001866.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg069"},{"key":"2026040108352068000_13.1.e001866.5","first-page":"739","article-title":"Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective","volume":"17","author":"Jeffries","year":"2008","journal-title":"Lupus (Los Angel)"},{"key":"2026040108352068000_13.1.e001866.6","doi-asserted-by":"publisher","DOI":"10.1080\/10245330701214145"},{"key":"2026040108352068000_13.1.e001866.7","doi-asserted-by":"publisher","DOI":"10.3109\/09537101003735564"},{"key":"2026040108352068000_13.1.e001866.8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjms.2019.03.002","article-title":"Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis","volume":"357","author":"Chen","year":"2019","journal-title":"Am J Med Sci"},{"key":"2026040108352068000_13.1.e001866.9","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1016\/S2352-3026(24)00144-3","article-title":"Diagnosis and management of Evans syndrome in adults: first consensus recommendations","volume":"11","author":"Fattizzo","year":"2024","journal-title":"Lancet Haematol"},{"key":"2026040108352068000_13.1.e001866.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.07.004"},{"key":"2026040108352068000_13.1.e001866.11","article-title":"Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine (Abingdon)"},{"key":"2026040108352068000_13.1.e001866.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-215368"},{"key":"2026040108352068000_13.1.e001866.13","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1182\/bloodadvances.2021005610","article-title":"Evans syndrome in adults: an observational multicenter study","volume":"5","author":"Fattizzo","year":"2021","journal-title":"Blood Adv"},{"key":"2026040108352068000_13.1.e001866.14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ajh.25574","article-title":"Evans syndrome in adults - incidence, prevalence, and survival in a nationwide cohort","volume":"94","author":"Hansen","year":"2019","journal-title":"Am J Hematol"},{"key":"2026040108352068000_13.1.e001866.15","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026040108352068000_13.1.e001866.16","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 EULAR\/ACR Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026040108352068000_13.1.e001866.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2026040108352068000_13.1.e001866.18","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/rheumatology\/keab925","article-title":"Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients","volume":"61","author":"Roussotte","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026040108352068000_13.1.e001866.19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583021"},{"key":"2026040108352068000_13.1.e001866.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100648"},{"key":"2026040108352068000_13.1.e001866.21","first-page":"829","article-title":"Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count","volume":"90","author":"Khellaf","year":"2005","journal-title":"Haematologica"},{"key":"2026040108352068000_13.1.e001866.22","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.644849"},{"key":"2026040108352068000_13.1.e001866.23","first-page":"514","article-title":"Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the \u201cAttikon\u201d cohort","volume":"29","author":"Nikolopoulos","year":"2020","journal-title":"Lupus (Los Angel)"},{"key":"2026040108352068000_13.1.e001866.24","first-page":"1542","article-title":"Differences in disease phenotype and severity in SLE across age groups","volume":"25","author":"Ambrose","year":"2016","journal-title":"Lupus (Los Angel)"},{"key":"2026040108352068000_13.1.e001866.25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/RHU.0000000000002239","article-title":"A Novel Scoring System for Diagnosing Systemic Lupus Erythematosus-Related Cytopenias: Insights From a Cohort Study","volume":"31","author":"Govea-Pel\u00e1ez","year":"2025","journal-title":"J Clin Rheumatol"},{"key":"2026040108352068000_13.1.e001866.26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.2022016818","article-title":"Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience","volume":"140","author":"Fattizzo","year":"2022","journal-title":"Blood"},{"key":"2026040108352068000_13.1.e001866.27","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/key119","article-title":"Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists","volume":"57","author":"Guitton","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2026040108352068000_13.1.e001866.28","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/ajh.70052","article-title":"Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients","volume":"100","author":"Marques","year":"2025","journal-title":"Am J Hematol"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:36:20Z","timestamp":1775057780000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/lupus-2025-001866"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001866","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}